Adrenomedullin dilates blood vessels through two independent mechanisms — direct smooth muscle relaxation AND endothelial nitric oxide release — making it an exceptionally potent vasodilator.
Dual vasodilatory mechanismAM works through both direct smooth muscle relaxation AND endothelial NO release, explaining its exceptional blood pressure-lowering potency
What the researchers found
Adrenomedullin dilates blood vessels through dual mechanisms — direct smooth muscle relaxation and endothelial NO release — with autocrine/paracrine production by vascular endothelial and smooth muscle cells.
Why it matters
Understanding AM's dual vasodilatory mechanism explains its exceptional potency and suggests it could be therapeutically valuable for conditions requiring blood vessel relaxation.
How the study worked
Review of adrenomedullin vascular biology covering production, receptor expression, signaling mechanisms, and roles in cardiovascular diseases.
What this study cannot tell us
Brief review with limited clinical data. The relative importance of each vasodilatory mechanism may vary between vascular beds.
How to read the evidence
Moderate evidence from a focused review of vascular adrenomedullin biology.
When this study was published
Published in 2000. Adrenomedullin's vascular role is well established, with ADM-targeting therapies in development for sepsis and heart failure.
The bigger picture
The vasculature has its own peptide signaling system for self-regulation. AM's autocrine/paracrine function means blood vessels can control their own tone independently of central nervous system input.
Questions still open
- Could AM administration treat hypertension or heart failure?
- Does AM's compensatory rise in heart failure help or hurt?
- Can AM be delivered to specific vascular beds for targeted therapy?
Common questions
What makes adrenomedullin special as a vasodilator?
Do blood vessels make their own blood pressure regulators?
Read the original research
Adrenomedullin: a new peptidergic regulator of the vascular function.
Clinical hemorheology and microcirculation, 23(2-4), 95-102
Citation
Minamino, N; Kangawa, K; Matsuo, H. (2000). Adrenomedullin: a new peptidergic regulator of the vascular function.. Clinical hemorheology and microcirculation, 23(2-4), 95-102.